OTC · Industrials

Bodhi Tree Biotechnology Inc (BDTB)

Bodhi Tree Biotechnology Inc brought in $37K of revenue over the twelve months to June 30, 2026. It posted a net loss of $116K. At June 30, 2026 it held $4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch BDTB in 60 seconds

Price

$0.28

0.00% on the day · October 22, 2026

52-week range $0.15 to $0.30

Market cap

$7.2M

Revenue (last 12 months)

$37K

Net margin

-313.6%

Key facts about Bodhi Tree Biotechnology Inc

Net worth: Bodhi Tree Biotechnology Inc has a market value (market cap) of $7.2M at the latest share price, and shareholders' equity of $13.8K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit: In fiscal 2025 revenue was $17K, with a net loss of $149.7K. Over the 12 months to June 30, 2026: revenue $37K, net loss $116K.
Cash flow: In fiscal 2025 operations used $150.2K of cash.
Latest report: The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report: Bodhi Tree Biotechnology Inc's next report is expected around December 28, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Bodhi Tree Biotechnology Inc does

Bodhi Tree Biotechnology Inc is registered with the SEC under industry code SIC 8742 (Services-Management Consulting Services). Its shares trade on OTC under the ticker BDTB.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$17K	-$147.6K	-$149.7K	-$0.01	n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around December 28, 2026.

Estimated from its filing rhythm: 52 weeks after its report of December 29, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where BDTB ranks in Industrials

Revenue$17K

#596 of 605 in Industrials · Bottom 1%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Industrials

Latest SEC filings

What Bodhi Tree Biotechnology Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 14, 2026
Quarterly report 10-Q · period to June 30, 2026Revenue was $10K; diluted EPS $0.00 versus $0.00.
May 14, 2026
Quarterly report 10-Q · period to March 31, 2026Revenue was $15K; diluted EPS $0.00 versus $0.00.
February 13, 2026
Quarterly report 10-Q · period to December 31, 2025Diluted EPS -$0.01 versus $0.00.
December 29, 2025
Annual report 10-K · period to September 30, 2025Revenue was $17K; diluted EPS was -$0.01.
August 12, 2025
Quarterly report 10-Q · period to June 30, 2025Diluted EPS $0.00 versus $0.00.
July 28, 2025
Quarterly report (amended) 10-Q/A · period to March 31, 2025Diluted EPS was $0.00.
June 6, 2025
Other event 8-K
May 20, 2025
Quarterly report 10-Q · period to March 31, 2025Diluted EPS was $0.00.
May 14, 2025
Late quarterly report notice NT 10-Q
February 21, 2025
IPO registration (amended) S-1/A

Insider trades

What the people running Bodhi Tree Biotechnology Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about BDTB

What does Bodhi Tree Biotechnology Inc do?

Bodhi Tree Biotechnology Inc is a company in the Industrials sector, listed on OTC as BDTB. Its shares trade on OTC under the ticker BDTB.

What is Bodhi Tree Biotechnology Inc's net worth?

Bodhi Tree Biotechnology Inc has a market value (market cap) of $7.2M at the latest share price, and shareholders' equity of $13.8K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Bodhi Tree Biotechnology Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $116K on revenue of $37K.

How much revenue does Bodhi Tree Biotechnology Inc make?

Over the twelve months to June 30, 2026 Bodhi Tree Biotechnology Inc reported revenue of $37K.

When did Bodhi Tree Biotechnology Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

When is Bodhi Tree Biotechnology Inc's next earnings report?

Bodhi Tree Biotechnology Inc's next report is expected around December 28, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

INTJ

Intelligent Group Ltd

CISO

CISO Global, Inc.

GRNQ

Greenpro Capital Corp.

ACCS

ACCESS Newswire Inc.

FOFO

Hang Feng Technology Innovation Co., Ltd.

LICN

Lichen International Ltd

Compare BDTB with

Compare BDTB with any company

Follow BDTB

Get an email when Bodhi Tree Biotechnology Inc files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values Bodhi Tree Biotechnology Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.